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Commensal bacteria are necessary for the development and maintenance of a healthy immune system.
Harnessing the ability of microbiota to affect host immunity is considered an important therapeutic strategy
for manymucosal and nonmucosal immune-related conditions, such as inflammatory bowel diseases (IBDs),
celiac disease, metabolic syndrome, diabetes, and microbial infections. In addition to well-established
immunostimulatory effects of the microbiota, the presence of individual mutualistic commensal bacteria
with immunomodulatory effects has been described. These organisms are permanent members of the
commensal microbiota and affect host immune homeostasis in specific ways. Identification of individual
examples of such immunomodulatory commensals and understanding their mechanisms of interaction
with the host will be invaluable in designing therapeutic strategies to reverse intestinal dysbiosis and recover
immunological homeostasis.Introduction
Mucosal surfaces are colonized by a complex and dynamic
microbial ecosystem termed ‘‘microbiota.’’ An astounding
number and diversity of microbes, including fungi, bacteria,
archaea, and viruses, are present in any given moment
throughout our bodies. The vast majority of these organisms
are not disease-causing invaders, but have made the host their
one-and-only home. Through coevolution, these ‘‘commen-
sals’’ have established one of the most impressive examples
of mutualistic relationship in the natural world, in which both
microbes and their animal host depend on each other for
optimal survival. Indeed, we rely on our microbiota for many
basic physiologic and metabolic functions, as well as proper
immune functions. Commensals provide immune protection in
several ways. They can defend their mucosal home by directly
combating invading pathogens or by mobilizing host antimicro-
bial immune defenses. They can also affect host immunity in a
more inconspicuous, but equally important, way by directing
the development of host immune cell subsets at steady state
and therefore affecting mucosal and systemic innate or
adaptive immune responses. Recent studies have identified
examples of commensal bacterial species with such immuno-
modulatory roles. The existence of multiple members of the
microbiota that affect host immune homeostasis in different
ways means that differences in the composition of this com-
munity may contribute to individual differences in immune
responses during infection, autoimmunity, cancer, or other
immunological conditions. Unveiling the underlying cellular
and molecular mechanisms of each of these examples holds
the promise to lead to exciting new ways for regulating mucosal
immunity.
Microbial-Host Interactions in the Intestine
Decades of studies in germ-free (GF) animals have established
the importance of microbiota for proper host immune function
(Macpherson and Harris, 2004). GF animals were first created496 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.more than a century ago (Nuttal and Thierfeledr, 1895–1896),
and long-term husbandry of GF rats has been possible since
the 1940s (Reyniers et al., 1946). However, until recently, the
composition of gut microbial communities remained largely
unknown. Advances in high-throughput sequencing in the last
few years have led to extensive cataloguing of the human
microbiota (Human Microbiome Project Consortium, 2012). In
addition to correlating changes in microbiota composition with
disease, this has allowed for the identification of commensal
species with specific immune effects. The vast majority of
these studies have focused on the bacterial component of the
microbiota; however, characterization of the fungal and viral
components and their function is under way (Iliev et al., 2012;
Reyes et al., 2012).
The individual’s microbiota composition is dynamic. It
changes with age and fluctuates with environmental changes,
such as geographical location, diet, antibiotic use, or influx and
efflux of external microbes (Clemente et al., 2012). In addition,
vastly different microbial communities reside in different parts
of the body (Costello et al., 2009). Based on their colonization
ability, bacteria in the gut can be transient or permanent. Tran-
sient bacteria represent microbes that are introduced during
adult life from the external environment and do not permanently
colonize the intestinal tract for various reasons, such as lack of
appropriate adaptations for colonization or inability to compete
with the resident microbiota. Many food-associated microbes,
including pathogens and conventional commercial probiotics,
are part of this category. Transient organisms can affect the
immune system in different ways and be innocuous, pathogenic,
or even beneficial, e.g., ingestion of probiotic-containing foods.
These organisms have not coevolved and therefore do not
establish a mutualistic relationship with the host, but rather
try to survive in the gut environment despite established host
defenses. Indeed, many acute intestinal pathogens have devel-
oped strategies to forcefully colonize the intestine, which in
most cases induces a strong immune response aimed at clearing
Table 1. Nonpathogenic Bacterial Members of the Intestinal Microbiota with Immune Effects
Concept Examplesa
Association
with Host Immune Effects Mechanismsa
Probiotics d Confer health benefit to
the host when administered
in adequate amount
d Not necessarily part of
the ‘‘normal microbiota’’
d May affect beneficial
microbiota (indirect effects)
Bifidobacterium spp;
Lactobacillus spp
Transient Innocuous,
immunostimulatory
Cytokine induction,
TLR activation, pathobiont
and pathogen suppression,
lactic acid, short-chain
fatty acids
Autobionts d Direct influence on host
immune cell homeostasis
or function
d Part of the ‘‘normal
microbiota’’
Bacteroides fragilis,
Clostridia XIVa and IV,
SFB, Faecalibacterium
prauznitsii
Permanent, host
dependent,
symbiotic
Immunomodulatory Largely unknown (TLR2,
metabolites [?], antigens [?],
effects on IEC function [?])
Pathobionts d Do not cause disease
in the presence of normal
microbiota in healthy host
d Cause disease when
microbiota or host
immunity is perturbed
Helicobacter hepaticus,
Clostridium difficile,
Prevotela spp.,
Klebsiella spp.,
Bilophila wadsworthia
Permanent,
parasitic/
infectious
Innocuous,
detrimental
Invasive mechanisms,
spore formation, toxins
(?), speculative mechanisms.
aExamples and mechanistic studies have been performed in mice (with the exception of F. prauznitsii and C. difficile). See text for details and
references.
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this inflammatory response may persist for years after the clear-
ance of the transient organisms, as in postinfectious irritable
bowel syndrome (Spiller and Garsed, 2009).
In contrast to transient bacteria, permanent bacteria are long-
term members of the microbial community. Their colonization
occurs in successive waves during ontogeny, and they have
developed evolutionary adaptations to establish a permanent
relationship with the host. In most cases they have coevolved
with the host and are not normally found as free-living organisms.
These are the true commensal bacteria. Commensals have mul-
tiple effects on the immune system of the host. On one hand,
the presence of a large number of ‘‘innocuous’’ bacteria has
immunostimulatory effects. Commensals stimulate general
recruitment of immune cells to themucosa, as well as generation
and maturation of organized gut-associated lymphoid tissues
(Macpherson and Harris, 2004). They also stimulate protective
epithelial cell functions, such as mucus and antimicrobial
peptide secretion (Hooper and Macpherson, 2010). On the other
hand, recent studies have identified the presence of commensal
species with immunomodulatory effects. These effects are
specific for individual bacteria or groups of bacteria, i.e., for
specific components of the microbiota. They involve reversible
changes in differentiation or effector function of host immune
cell subsets. In this way, microbiota composition can influence
the type and robustness of host immune responses. Here, we
refer to such permanent microbiota members with immunomod-
ulatory effects as autobionts. In contrast to transient pathogens
or pathobionts (see below), the immune effects of autobionts are
more subtle because they do not cause any overt change in the
health state of the host. Rather, they help maintain and regulate
the host’s healthy immune steady state. Permanent microbiota
members that can demonstrate detrimental effects under
special conditions are called pathobionts. Pathobionts colonizethe host, but do not cause disease with a full complement of
normal microbiota. However, they can expand and cause
disease if microbiota or host immune homeostasis is perturbed
(for example, after antibiotic treatment or under conditions of
intestinal inflammation). The immune effects and characteristics
of different intestinal bacteria are summarized in Table 1.
In contrast to pathogens, pathobionts, and even probiotics,
very little is known about the mechanisms by which autobionts
exert their immunomodulatory effects. Until recently, one reason
for this was the lack of specific examples of immunomodulatory
commensals. Another reason is the difficulty in culturing these
organisms ex vivo and the relative lack of genetic tools to study
their genome function. In this review we focus on recently
described examples of immunomodulatory commensals and
speculate on potential cellular and molecular mechanisms
involved in their interaction with the host and the establishment
of a healthy steady immune state. Knowledge of these mecha-
nisms can benefit the development of future therapies for intes-
tinal diseases (Clemente et al., 2012).
The Intestinal Microbial Community Influences
Immunity
During steady-state conditions, the microbiota affects the devel-
opment and function of various immune cell populations,
including IgA-secreting plasma cells, Th17 cells, regulatory T
(Treg) cells, invariant natural killer T (iNKT) cells, gdT cells, NK
cells, macrophages, dendritic cells (DCs), and innate lymphoid
cells (ILCs) (Honda and Littman, 2012). For example, IgA+
plasma cells in gut lymphoid tissues and lamina propria (LP)
are greatly reduced in GF or antibiotics-treated conventional
animals (Macpherson and Harris, 2004). In another example,
the abundance and function of CD4+ T cells expressing the
FoxP3 transcription factor (Tregs) or interleukin (IL)-17 (Th17
cells) in the intestinal mucosa at steady state are affected byCell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc. 497
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of both Tregs and Th17 cells are markedly reduced, and expres-
sion of the immune-suppressive cytokine IL-10 in Treg cells is
severely reduced (Atarashi et al., 2008, 2011; Ivanov et al.,
2008). These reductions are quickly restored by transplantation
of intestinal or fecal microbiota from conventionally raised/
specific pathogen-free (SPF) mice. As described below, the
development of these CD4+ T cell subsets is differentially regu-
lated by certain components of the intestinal microbiota
includingBacteroides fragilis, Clostridia species, and segmented
filamentous bacteria (SFB) (Atarashi et al., 2011; Ivanov et al.,
2009; Round and Mazmanian, 2010) (Table 1). Th17 cells
contribute to host defense against infection with pathogenic
microbes but can also augment harmful autoinflammatory func-
tions, whereas Tregs play critical roles in immune suppression.
Therefore, under healthy conditions Th17 cells and Tregs should
coexist in a well-regulated balance. The particular combinations
and relative abundances of the corresponding commensal
species would generate distinct immune environments and
immune responses in the host.
In addition to inducing development or recruitment of host
immune cell subsets, microbiota may also affect the function
of these subsets. For example, gut microbiota provides an envi-
ronment not only for the accumulation of IgA+ cells but also for
the functional maturation of IgA+ plasma cells by inducing the
generation of iNOS+ IgA+ plasma cells (Fritz et al., 2012).
iNOS+ IgA+ plasma cells are absent in GF mice but present in
conventionally raised mice. This subset plays critical roles in
the enhancement of IgA+ plasma cell development and the
host defense against enteric pathogens, such as Citrobacter
rodentium (Fritz et al., 2012). Commensal bacteria also affect
NK cell function. Even though NK cell numbers are normal in
GF mice, NK cell priming and antiviral activity is deficient in the
absence of microbiota (Ganal et al., 2012). This effect is due to
microbiota-directed introduction of epigenetic changes and
induction of type I interferons from monocytic macrophages,
which are required for proper NK cell priming (Ganal et al., 2012).
Microbiota-controlled immune effects may also play role in
regulation of the microbiota itself. Commensal-induced IgA+
plasma cells contribute to controlling microbiota abundance
and composition. For instance, mice carrying a knockin mutation
of activation-induced cytidine deaminase (AID) (AIDG23S), which
can mediate normal IgA class switching but cannot induce
somatic hypermutation and high-affinity IgA responses, exhibit
excessive proliferation of anaerobic bacteria in the small intes-
tine (Wei et al., 2011). Similar overgrowth of microbiota was
also reported in programmed cell death-1 (PD-1)-deficient
mice, which have increased follicular helper T (TFH) cell develop-
ment, and therefore low-affinity IgA-producing plasma cells are
aberrantly selected in germinal centers (Kawamoto et al.,
2012). Thus, microbiota is required for the development of fully
functional IgA+ cells, which in turn function to maintain microbial
homeostasis in the gut.
The microbiota also plays suppressive roles in immune cell
function and accumulation in the gut. For example, it represses
constitutive production of IL-22 in lymphoid tissue inducer (LTi)
cells and NKp46+ cells (both of which are RORgt+ ILCs; see
detailed review by Tait Wojno and Artis, 2012 in this issue of
Cell Host & Microbe) through epithelial expression of IL-25498 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.(Sawa et al., 2011). Another example is that early exposure to
gut microbiota provides an epigenetic suppressive marking in
the regulatory element of CXCL16 gene in the host, resulting in
lifelong suppression of CXCL16 expression in gut and lung (Ols-
zak et al., 2012). This suppression is accompanied by reduced
abundance of iNKT cells in the colon and lung at steady state
and affects host resistance to colitis and asthma (Olszak et al.,
2012). Taken together, intestinal microbiota provide diverse
signals for activation and suppression of the immune system,
thereby having the ability to skew host immune status toward
either effector or regulator dominance.
Commensals have immunomodultory functions not only in the
intestine. For example, resident commensals in the skin induce
local Th17 and Th1 responses that are crucial in protection
from bacterial infections (Naik et al., 2012). More importantly,
these responses were compartmentalized to the skin and were
independent of gut commensals (Naik et al., 2012).
Commensals influence pathogenesis of many diseases.
Because this community is evolutionarily established to sustain
healthy immune steady state, any major perturbations in its
composition may have negative effects and perpetuate the cycle
of chronic inflammation, allergy, or metabolic syndrome. Such
‘‘dysbiosis’’ can be induced by diet, pharmacological agents,
infection, inflammation, and host genetics (Honda and Littman,
2012). Once established, the dysbiotic microbiota may become
stable and transplantable to GF or even conventionally raised
animals. Indeed, cohousing of wild-type mice with disease-
prone mutant mice, such as Tbet/Rag/, Nrlp6/, or Asc/
mice, results in transfer of dysbiotic microbiota and predisposi-
tion of the wild-type mice to disease, including colitis and
metabolic syndrome (Elinav et al., 2011; Garrett et al., 2007;
Henao-Mejia et al., 2012).
Dysbiosis may lead to elimination of beneficial bacteria or
outgrowth of pathobionts. Pathobionts are permanent members
of the microbiota, present at low levels and innocuous under
normal conditions (Table 1). They can become pathogenic if al-
lowed sufficient expansion due to loss of microbiota or immune
homeostasis. For instance, overgrowth of members of Prevotel-
laceae and TM7 has been implicated in host susceptibility
to DSS colitis in Nrlp6/ mice (Elinav et al., 2011). In Tbet/
Rag/ mice, Proteus mirabilis and Klebsiella pneumoniae
were identified to, at least in part, be responsible for the pheno-
type of spontaneous colitis (Garrett et al., 2010). Most impor-
tantly, disease susceptibility was transferable to wild-type mice.
The composition of the gut microbiota is also altered by
diet. Milk fat- and taurocholic acid-rich diets induced marked
increase in Bilophila wadsworthia colonization, which is associ-
ated with enhancement of Th1 responses and acceleration
of colitis development in Il10/ mice (Devkota et al., 2012).
It should be noted that, depending on the host genotype, other-
wise innocuous symbionts may become pathogenic. Indeed,
in an inflammatory bowel disease (IBD) mouse model with
deficiencies in IL-10 and TGF-b signaling, Bacteroides thetaio-
taomicron, a well-characterized symbiotic species, potently
induces colitis (Bloom et al., 2011).
Autobionts—Mutualistic Immunomodulatory Microbes
As discussed above, there is abundant evidence that microbiota
directs host immunity. Regulation of immune responses by
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different cells of the immune system is especially interesting,
because it results not simply from the presence of innocuous
bacteria, but from the biological activity of commensals. In
many cases these effects are functionally distinct, e.g., induction
of Th17 cells versus Tregs, and depend on the activity of different
members of the commensal community. The relative abundance
of these ‘‘autobionts’’ can direct the general type of immunity
in the host mucosa of an individual at a given time. Currently
there are relatively few specific examples of commensals with
immunomodulatory effects as discussed below. More are surely
going to be identified in the future.
Despite considerable species diversity, the intestinal micro-
biota in most mammals consists of bacteria belonging to two
major phyla—Gram-negative Bacteroidetes and Gram-positive
Firmicutes. This probably reflects evolutionary adaptations of
these phyla to survive in the gut environment, and both of
them contain important immunomodulatory commensals.
Bacteorides fragilis Promotes Treg Function
B. fragilis was the first commensal to be implicated in affecting
T helper cell balance by promoting Th1 development systemi-
cally (Mazmanian et al., 2005). However, further studies showed
that B. fragilis also affects mucosal T cell homeostasis by
promoting regulatory T cell function (Round and Mazmanian,
2010). B. fragilis is a Gram-negative member of the phylum
Bacteroidetes. It is not a very abundant member of the gut
microbiota; however, the genus Bacteroides is well represented
in human gut and has a superior ability to utilize the nutrients in
the gut microenvironment (Flint et al., 2008). For example, the
genome of the prototypical dominant commensal member
of the class, B. thetaiotaomicron, contains several hundred
proteins involved in harvesting and metabolizing of dietary poly-
saccharides (Sonnenburg et al., 2005). These are probably
adaptations that have allowed Bacteroides to establish mutual-
istic relationship with the host, by (1) being able to flourish in
the plant polysaccharide-enriched gut environment and (2) being
able to provide biological ‘‘byproducts’’ necessary for the well-
being of the host. Different Bacteroidetes species produce
different beneficial biological byproducts, which may have
helped establish them as permanent symbionts. For example,
B. thetaiotaomicron is one of the major producers of short-
chain fatty acids (SCFAs), which are necessary for proper host
metabolic and immune functions. B. fragilis seems to have
pronounced immunomodulatory functions. B. fragilis is not
normally present in conventionally raised SPF mice, and coloni-
zation with B. fragilis protects mice from colitis in the T cell
transfer and 2,4,6-trinitrobenzene sulfonic acid (TNBS) models
(Mazmanian et al., 2008). This protection is due to the expansion
of immune-suppressive IL-10 producing Tregs by the bacteria
(Round and Mazmanian, 2010). The introduction of B. fragilis
as a permanent member of the microbiota also affects T cell
homeostasis in the absence of inflammation. Colonization of
SPF or GF mice with B. fragilis leads to an induction of IL-10
production by Foxp3+ Tregs even at steady state (Round and
Mazmanian, 2010). Thus,B. fragilis colonizationmodulates intes-
tinal T cell homeostasis by boosting Treg function. This anti-
inflammatory effect of the bacteria likely represents an evolu-
tionary adaptation for establishing mutualism. Indeed, whenTregs were depleted, B. fragilis could not efficiently colonize
host tissues (Round et al., 2011). Most importantly, the
identification of B. fragilis as a modulator of Treg function
allowed for investigation of the bacterial and host mechanisms
involved. It was found that the anti-inflammatory effects of
B. fragilis require the expression of bacterial capsular polysac-
charide A (PSA). PSA-deficientB. fragilismutantswere incapable
of inducing IL-10 production by Tregs and did not provide
protection from colitis (Mazmanian et al., 2008; Round and
Mazmanian, 2010). Instead, lack of PSA expression led to expan-
sion of Th17 cells and loss of themutualistic ability ofB. fragilis to
colonize host tissues (Round et al., 2011).Moreover, treatment of
mice with purified PSA is sufficient to replicate the effects of the
bacteria, including induction of IL-10 production by Tregs,
suppression of Th17 cell production, protection in colitis models,
and colonization of the host (Mazmanian et al., 2008; Round
et al., 2011; Round and Mazmanian, 2010). These studies re-
present an elegant example of how investigating an immu-
nomodulatory commensal and its effect on the host immune
system can lead to elucidation of underlying molecular mecha-
nisms and identification of clinically relevant immunomodulatory
molecules.
Cluster IV and XIVa Clostridia Induce Treg
Differentiation
Intestinal Clostridia are a heterogeneous group that forms the
core of Firmicutes of the normal commensal microbiota. Clostri-
dia areGram-positive, rod-shaped, endospore-forming bacteria.
They are a highly heterogeneous class that is composed of at
least 19 clusters based on genomic similarity (Collins et al.,
1994). The prototypical Clostridia from cluster I contain frequent
environmental toxin-producing members, such as Clostridium
perfringens, C. difficile, and C. tetani. These Clostridia may be
present in the intestine, but usually as transient pathogens or,
at best, pathobionts (e.g., C. difficile). In contrast, most com-
mensal intestinal Clostridia are nontoxinogenicmembers of clus-
ters XIVa and IV. They are typically described as fusiform-shaped
bacteria and constitute 10%–40% of the total microbiota (Frank
et al., 2007). Cluster XIVa includes the genera Clostridium, Eu-
bacterium, Ruminococcus, Coprococcus, and Roseburia. The
cluster IV group includes species belonging to the Clostridium,
Faecalibacterium, and Ruminococcus genera. Clostridia colo-
nize the mucus layers in the vicinity of the epithelium, in contrast
to Bacteroidaceae, Enterococcaceae, and Lactobacillaceae,
which colonize in regions of the central lumen, suggesting unique
influences of Clostridia on host physiology (Nava and Stappen-
beck, 2011). Indeed, the cluster XIVa Lachnospiraceae family
is significantly less abundant in IBD patients compared to
healthy subjects (Frank et al., 2007). Loss of mucosa-associated
Clostridia and cluster IV Clostridia, particularly Faecalibacterium
prausnitzii, is observed in IBD patients (Sokol et al., 2008).
Although it remains unclear whether the decrease in Clostridia
is a cause or effect of chronic inflammation, it is likely that main-
tenance of the Clostridia community is necessary to prevent IBD.
In addition to the role in the intestinal (local) immunehomeostasis,
Clostridia also affect systemic immunity. Indeed, it has been
shown that reduction of Clostridia clusters XIVa and IV by neo-
natal vancomycin treatment promotes airway hypersensitivity in
a mouse model (Russell et al., 2012). Furthermore, decreasedCell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc. 499
Cell Host & Microbe
Reviewabundances of clusters IV and XIVa Clostridia have been associ-
ated with atopy during childhood (Candela et al., 2012).
The levels of Clostridia clusters IV and XIVa in adult mouse
colon microbiota were found to correlate with the numbers of
Tregs (Atarashi et al., 2011; Russell et al., 2012). Consistent
with a role in colonic Treg induction, GF mice colonized with
46 strains of Clostridia clusters XIVa and IV showed accumula-
tion of Treg cells in the colon (Atarashi et al., 2011). The 46 strains
of Clostridia were originally isolated from the sporulating micro-
biota fraction of conventional mice based on their capacity to
normalize the enlarged cecum in GF mice (Itoh and Mitsuoka,
1985). These Clostridia were found to induce near steady-state
numbers of colonic Tregs in GF mice, in contrast to other intes-
tinal bacteria including Treg-associated autobionts such as
B. fragilis (Atarashi et al., 2011). Whereas most Treg cells in the
colon of GF mice were Helioshi, which has been proposed as
a marker for thymically derived Treg cells (Thornton et al.,
2010), Treg cells in mice colonized with 46 strains of Clostridia
clusters XIVa and IV were mostly Helioslo (Atarashi et al., 2011),
suggesting that Clostridia robustly trigger peripheral differentia-
tion of induced Treg (iTreg) cells. Consistent with these findings,
colonization of GF mice with altered Schaedler flora (ASF),
a defined bacterial cocktail containing eight enteric species
that includesClostridium clostridioforme, induces the accumula-
tion of Treg cells in the colon (Geuking et al., 2011). Treg cells in
the intestine exhibit different characteristics from those in
secondary lymphoid organs, and they express CD103, killer
cell lectin-like receptor G1 (KLRG1), granzyme B (Gzmb),
IL-10, and IL-35 (Feuerer et al., 2010). In particular, IL-10 plays
an indispensable role in the suppression of aberrant activation
of Th17 cells, myeloid cells, and gdT cells in the intestine. Indeed,
Treg-specific disruption of IL-10 results in severe colitis (Rubtsov
et al., 2008), as does a Treg-specific deficiency of STAT3, which
regulates many of the above-mentioned genes (Chaudhry et al.,
2009). STAT3-deficient Tregs lack IL-10 expression and the
mice develop spontaneous, Th17-mediated, commensal micro-
biota-dependent fetal colitis (Chaudhry et al., 2009). Coloniza-
tion of GF mice with the 46 strains of Clostridia clusters XIVa
and IV induced not only an increase in Treg numbers but also
high levels of IL-10 production (Atarashi et al., 2011). In humans,
F. prausnitzii, which belongs to Clostridium cluster IV, increases
IL-10 expression in peripheral blood mononuclear cells in vitro
(Sokol et al., 2008). Therefore, autochthonous Clostridia con-
stitutively induce accumulation and functional activation of
Tregs in the colon and the relative abundance of Clostridia
in the microbiota may strongly affect the immune status of the
host.
SFB Induce Th17 Cell Differentiation
T cell homeostasis in the intestine can be defined as the balance
between T cell subsets that promote immune responses and
T cell subsets that subdue immune responses. IL-17-producing
Th17 cells are proinflammatory CD4 T cells that contribute to
disease pathogenesis in a number of chronic autoimmune
inflammatory conditions, including IBD, multiple sclerosis, rheu-
matoid arthritis, psoriasis, and certain cancers. At the same time,
Th17 cells are crucial for efficient immune responses against
mucosal pathogens, including viruses, bacteria, and fungi.
Th17 cells differentiate from naive T cells under the combined500 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.effects of TGF-b and proinflammatory cytokines, such as IL-6,
IL-23, and IL-1b. The latter group of cytokines is upregulated in
secondary lymphoid tissues during certain infections, which
instructs Th17 cell differentiation in this context. However, at
steady state, in the absence of infection or overt inflammation,
Th17 cells are highly enriched in the intestinal LP and are not
present in secondary lymphoid tissues (Ivanov et al., 2006). In
the gut, Th17 cells coexist with Foxp3+ Tregs. The two subsets
share common developmental pathway and alternative differen-
tiation fates. This includes shared dependence on TGF-b and
direct interaction and mutual functional inhibition of the two
master transcriptional regulators, RORgt (Th17 cells) and
FoxP3 (Tregs) (Zhou et al., 2008). This overlap of cytokine and
transcriptional networks results in an elegant balance between
two functionally opposing T cell subsets. Importantly, this
balance is flexible and can be quickly reversed depending on
the required immune response. One of the most important
factors controlling the homeostasis between these two T cell
subsets in the gut is the composition of intestinal microbiota.
Th17 cells are not present in GF mice but are induced upon
colonization with the full complement of gut bacteria from SPF
mice (Atarashi et al., 2008; Ivanov et al., 2008). In contrast,
colonization with culturable intestinal isolates, including Treg-
inducing commensals, such as B. fragilis or the mix of 46 Clostri-
dia described above, does not lead to Th17 cell induction (Ivanov
et al., 2009; Round et al., 2011), arguing that commensal micro-
biota contains unknown Th17 cell-inducing bacteria. This was
further supported by the discovery that C57BL/6 mice from
a colony at the Jackson Laboratory did not contain gut Th17 cells
due to the lack of Th17-cell-inducing bacteria and that total
microbiota from these mice could not induce Th17 cells in GF
animals, in contrast to microbiota from C57BL/6 mice from
a colony at Taconic Farms (Ivanov et al., 2008). Comparison of
the microbiota between these two colonies revealed that
Taconic B6 mice are highly enriched in SFB, which are absent
from Jackson B6 mice (Ivanov et al., 2009). Interestingly, mono-
colonization of GF animals with SFB or introduction of SFB into
Jackson B6 mice induces Th17 cell differentiation in the LP
(Gaboriau-Routhiau et al., 2009; Ivanov et al., 2009), identifying
SFB as a Th17-cell-inducing autobiont.
SFB are Gram-positive anaerobic bacteria that are known to
permanently colonize the intestinal tract of many animal species.
SFB or SFB-like bacteria have been described in invertebrates,
such as termites and cockroaches, and in vertebrate animals
such as fish, chickens, rabbits, mice, rats, cats, dogs, sheep,
cows, pigs, zebras, and monkeys (Klaasen et al., 1992). How-
ever, SFB have not yet been detected in humans (Sczesnak
et al., 2011). SFB are members of the Firmicutes phylum and,
based on the 16S rRNA sequence, were assigned to Clostridia
(Snel et al., 1995). The similarity to Clostridia was later confirmed
by the full SFB genomic sequence (Sczesnak et al., 2011). In
fact, more than 60% of SFB ORFs are derived from Clostridial
ORFs (Sczesnak et al., 2011). Despite this close similarity, SFB
do not cluster with any of the sequenced Clostridial genomes.
Moreover, the SFB genome is almost three times smaller than
the average Clostridial genome. Such genome reduction is
typical for obligate symbionts and therefore may be amutualistic
evolutionary adaptation to establish SFB as a permanent
member of the gut microbiota.
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overt pathology, such as intestinal inflammation. It is unclear
why SFB-induced Th17 cells do not induce inflammation. It
could be due to control by Tregs and the opposing effects of
Treg-inducing autobionts. However, SFB-monocolonized mice
do not develop spontaneous colitis, which argues against
suppressive effects of other bacteria. Another possibility is that
either the levels or the effector function of SFB-induced Th17
cells are not sufficient for induction of inflammation. Indeed,
naturally occurring intestinal Th17 cells do not cause colitis in
the T cell transfer model of colitis, in contrast to transfer of
Th17 cells isolated from colitic mice (Ono et al., 2012). Small
intestinal Th17 cells, presumably induced by microbiota, even
had some regulatory activity in this model (Ono et al., 2012).
Thus, Th17 cells induced by SFB may be qualitatively different
from pathogenic Th17 cells induced during colitis. The lack of
pathological changes in the face of induction of a ‘‘proinflamma-
tory’’ T cell subset may reflect an evolutionary adaptation that
has helped preserve SFB as part of the microbiota. This also
suggests that SFB, SFB-induced Th17 cells, and other SFB
immunomodulatory effects are beneficial for the host. Indeed,
SFB colonization leads to improved protection against infections
with intestinal pathogens, as shown for Citrobacter rodentium
in mice and enteropathogenic E. coli in rabbits (Heczko et al.,
2000; Ivanov et al., 2009). Th17 cells are important mediators
of protection against intestinal infections, which could be the
underlying mechanism of SFB-mediated protection. However,
SFB have other more general immunostimulatory effects, such
as induction of IgA production, general CD4 T cell and IEL
accumulation (Umesaki et al., 1995), and stimulation of antimi-
crobial peptide production from epithelial cells (Ivanov et al.,
2009). Therefore, whether the protective effects of SFB are
mediated by Th17 cells remains to be established. SFB are
currently the only known commensal species, and hence the
only autobiont, that can induce Th17 cells, even though indirect
evidence suggests that other Th17 cell-inducing commensals
may exist (Atarashi et al., 2008; Ivanov et al., 2009).
Mechanisms of Commensal Immunomodulatory Effects
As defined and discussed here, autobionts are commensal
bacteria that modulate immune homeostasis by affecting the
development, differentiation, or effector function of different
immune cell subsets. Whether these effects represent a natural
immune response to the presence of the bacteria or amutualistic
adaptation has not been clearly established in all cases.
However, the immune changes induced by autobionts possess
several characteristics that distinguish them from conventional
immune responses against pathogens or other commensals.
First, the response is unique for the bacteria. For example,
SFB is the only known commensal to induce Th17 cells. Second,
the response itself is specialized and usually restricted to a
certain immune cell subset. For example, the presence of
commensal bacteria induces a general recruitment of all
lymphoid subsets to the gut and maturation of secondary
lymphoid structures. A pathogen invasion will induce a full
cascade of proinflammatory immune responses, such as release
of a battery of proinflammatory cytokines and infiltration of
multiple immune cell subsets. In contrast, B. fragilis predomi-
nantly induces IL-10 production from Tregs, Clostridia fromclusters IV and XIVa induce Foxp3+ Tregs, and SFB induce
specifically Th17 cells. Most importantly, the effects of
autobionts are ‘‘subtle’’ and do not present as overt immune
changes, such as immune deficiency or inflammation. Invasive
intestinal pathogens also induce Th17 cells, but in contrast
to SFB, this induction is part of the general tissue damaging
inflammatory immune response with induction and infiltra-
tion of multiple inflammatory subsets. Thus, the effects of
autobionts are fundamentally different from those of pathogens
or innocuous commensals. Therefore, characterization of the
molecular and cellular mechanisms underlying these effects
is of particular interest and may be extremely relevant for the
development of immunomodulatory therapies with low side
effects.
Modification of Pattern-Recognition Receptor Signaling
Toll-like receptors (TLRs) and Nod-like receptors (NLRs) are
crucial innate immune receptors for the general detection of
bacteria. They are also crucial for the establishment of intestinal
homeostasis by the microbiota. Loss of TLR signaling negatively
affects intestinal epithelial cell (IEC) regeneration after injury and
aggravates intestinal inflammation (Rakoff-Nahoum et al., 2004).
Ligation of TLRs by commensals may also inhibit immune acti-
vation by IECs through various mechanisms (Cerf-Bensussan
and Gaboriau-Routhiau, 2010). Deficiencies in pattern-recogni-
tion receptor (PRR) signaling also control homeostasis at the
level of microbiota composition. Indeed, genetic deficiencies of
Nod1, Nod2, Nlrp3, and Nlrp6 have all been shown to affect
microbiota homeostasis, which leads to increased disease
susceptibility (Bouskra et al., 2008; Elinav et al., 2011; Henao-
Mejia et al., 2012; Petnicki-Ocwieja et al., 2009). Interestingly,
all these studies involved perturbations of NLR signaling. In
contrast, a recent comprehensive study demonstrated that
loss of TLR signaling does not affect microbiota composition
and that the distinct microbiota composition of TLR-deficient
mice is due to housing isolation rather than defective innate
immunity (Ubeda et al., 2012). Regardless of its effects onmicro-
biota composition, TLR activation is likely to be involved in
mediating immunomodulatory effects of commensals in general.
The effects of B. fragilis and PSA on Th1 and Treg function
require TLR2 signaling (Round et al., 2011). TLR2 expression
seems to be required on Tregs themselves in vitro, although
whether this is the case in vivo remains to be investigated (Round
et al., 2011). In contrast, induction of Tregs by the 46 strains of
Clostridia occurred normally after colonization of GF Myd88/
mice, which lack the signaling adaptor for several TLRs (Atarashi
et al., 2011), although whether it is controlled by other PRRs has
not been investigated. Whether TLR signaling is involved in the
induction of Th17 cells by SFB is not completely clear. Th17 cells
are still present in normal numbers in the LP of SPF Myd88/
mice, as well as in Myd88/Trif/ mice, which lack both TLR
signaling adaptors and therefore all TLR signaling, or Rip2/
mice, which lack downstream Nod1/2-signaling (Atarashi
et al., 2008; Ivanov et al., 2008, 2009). However, full genome
sequencing of SFB has revealed that SFB harbor flagellar
assembly proteins with flagellins capable of binding to TLR5
(Kuwahara et al., 2011). Moreover, there are reports that TLR
signaling is important for intestinal Th17 cell generation. The
numbers of Th17 cell-bound RORgt+ CD4 T cells, as identifiedCell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc. 501
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MyD88 (Shaw et al., 2012). In support of this, Tlr9/ mice
have decreased numbers of LP Th17 cells (Hall et al., 2008).
An additional complication is potential heterogeneity of
responses through different TLRs mediated by different com-
mensals. For example, it is possible that activation of some
TLRs inhibits, while activation of other TLRs promotes, Th17
cell differentiation. In this scenario, ablation of signaling through
both activating and inhibitory TLRs in Myd88/ mice will not
lead to considerable changes in Th17 cell number. The precise
role of PRRs in the Th17 cell inductive capacity of total micro-
biota and specific commensals, such as SFB, awaits controlled
colonization experiments.
Modification of LP Immune Cell Function and Antigen
Specificity
Autobionts are noninvasive members of the luminal microbiota;
however, they affect immune cell function in the LP and even
systemically. In most cases, the affected host cells are not in
direct contact with the bacteria. Rather, they interact with bacte-
rial products or are affected by the activity of bacteria-detecting
cells. The nature of the immune cells involved in inducing Th17 or
Treg cells by commensals is an area of active investigation.
Naive T cells differentiate into effector cells upon appropriate
activation by a cognate antigen in the context of an appropriate
cytokine environment. Therefore, T cell-modulating commen-
sals, such as SFB and Clostridia, must specifically affect one,
or both, of these processes. The specificity can be provided by
induction of a unique cytokine environment, an appropriate level
of TCR stimulation by commensal-deriver antigens, or both.
These signals can be transmitted to T cells by the activation
of unique subsets of immune cells in the LP. DCs are major
modulators of T cell responses, because they can serve as
potent antigen-presenting cells (APCs) and at the same time
contribute to the local cytokine environment through detection
of microbial substances by their PRRs. The intestinal LP harbors
distinct subsets of intestinal DCs (iDCs), and several of them
have been implicated in regulating intestinal T cell homeostasis
and in particular the Th17/Treg balance (Bogunovic et al.,
2012; Varol et al., 2010). iDCs can produce the major cytokines
involved in Th17 and Treg differentiation, including IL-6, IL-23,
and TGF-b, and have been directly implicated in regulating
T cell homeostasis (Swiatczak and Rescigno, 2012). Indeed,
iDCs have been shown to induce Treg and Th17 cell differentia-
tion in vitro. CD103+ iDCs induce Treg differentiation in vitro
through the production of the vitamin A-derived nuclear hormone
receptor agonist retinoic acid (RA) (Coombes et al., 2007; Sun
et al., 2007). A number of different iDC subsets have been shown
to induce Th17 cell differentiation in vitro, including CD70hi,
TLR5+, and CD11b+CD103+ DCs (Atarashi et al., 2008; Denning
et al., 2011; Uematsu et al., 2008). However, the exact contribu-
tion of any of these iDC subsets, or even iDCs in general for
Th17 or Treg induction in vivo, is not completely clear. Probably
the most direct data come from studies of DC-specific deletion
of various molecules. DC-specific deletion of Notch2 leads to
a specific loss of the CD103+CD11b+ iDC subset with corre-
sponding decrease in Th17, but not Treg, cell differentiation,
which seems to implicate this subset in Th17 rather than Treg
induction (Lewis et al., 2011). iDCs express the integrin avb8,502 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.which is an important activator of intestinal TGF-b, a cytokine
crucial for both Th17 and Treg differentiation. DC-specific dele-
tion of integrin av or b8 leads to significant disruption in Treg
and Th17 cell differentiation and development of colitis (Acharya
et al., 2010; Lacy-Hulbert et al., 2007; Paı¨dassi et al., 2011; Travis
et al., 2007). In addition, DC-specific loss of the transcription
factors T-bet and Stat3, the cytokine IL-10, and theWnt signaling
mediator b-catenin all lead to disrupted Th17/Treg balance
and chronic colitis (Garrett et al., 2007; Manicassamy et al.,
2010; Melillo et al., 2010). Therefore, although a role for iDCs in
regulating gut T cell homeostasis seems obvious, the exact
contribution of different DC subsets in vivo will need to be exam-
ined further. In contrast, the role of iDCs in microbiota-mediated
immune effects is not known. Even thoughCD103+ iDCs express
RA-producing enzymes and are capable of promoting Treg
induction in vitro, whether the in vivo effects of autobionts,
such as Clostridia or B. fragilis, are mediated through iDCs
remains to be investigated. In the case of Th17 cells, SFB colo-
nization or colonization with other Th17 cell-inducing bacteria
stimulates production of Th17 cell-regulating cytokines, e.g.,
IL-23, IL-6, and TGF-b, from LPDCs (Atarashi et al., 2008; Ivanov
et al., 2009). CD103+CD11b+ DCs isolated from mice with Th17
cell-inducing microbiota were the only gut DC subset capable of
inducing Th17 cells in vitro (Denning et al., 2011), and this was
dependent on microbiota effects, because the same cells iso-
lated from Jackson B6 mice (that lack SFB and Th17 cells)
were deficient in Th17 cell induction. The exact role of DCs in
SFB-mediated induction of Th17 cells in vivo remains to be
established.
LP DCs may mediate T cell induction by commensals in
several ways. They may sample commensal-derived antigens,
either by directly contacting the bacteria through extension of
dendrites into the gut lumen (Rescigno et al., 2001) or by detect-
ing bacterial products that gain access to the LP. They may
then present these antigens to intestinal T cells to induce
commensal-specific T cells. Alternatively, LP DCs may be con-
ditioned by commensals indirectly, e.g., by cytokines produced
by other cells in response to the bacteria. For example, SFB
attachment may induce cytokine production by IECs that may
modulate DC function. Indeed, SFB induce serum amyloid A
(SAA) production from IECs, which in turn may stimulate DC
production of IL-23 (He et al., 2006; Ivanov et al., 2009), a cyto-
kine required for Th17 cell maintenance.
Another important question that will help shed light onto auto-
biont-specific mechanisms is this: what are the antigen specific-
ities of autobiont-induced Th17 and Treg cells? If autobionts
provide antigens to induce autobiont-specific T cells, identifica-
tion of the APCs involved can help identify cells that receive
signals from the commensal as well as how commensals or their
antigens are detected by the immune system. At the same time,
characterization of Treg or Th17-cell-inducing autobiont-derived
antigens will identify potential commensal genes involved in
the process, which may help pave the path for design and
development of microbial products as immunomodulatory
therapeutics. On the other hand, if most autobiont-induced
T cells are not specific for the bacteria, autobionts are mostly
affecting cytokine environment in the gut. A recent study using
high-throughput sequencing demonstrated that a large propor-
tion of inducible colonic Tregs recognize commensal-derived
Cell Host & Microbe
Reviewantigens (Lathrop et al., 2011). It has also been shown that
Foxp3+ Tregs with TCRs that are specific for flagellins related
to those of Clostridia cluster XIVa contribute to the induction of
IgA+ B cells in the intestine (Cong et al., 2009). Still, it is currently
not known whether Tregs induced by commensal Clostridia are
mostly specific for Clostridial antigens. In the case of Th17 cells,
one study found that Th17 cells still develop in the gut of non-
commensal TCR-transgenic (Tg) mice, which argues that
presentation of commensal antigens is not required for Th17
cell induction (Lochner et al., 2011). Surprisingly, T cell activation
and Th17 cell differentiation still occurred in the absence of
cognate antigen (Lochner et al., 2011), which may reflect poten-
tial crossreactivity of the Tg TCRs to unknown endogenous or
commensal-derived antigens. In contrast, in another study,
transferred activated TCR Tg T cells did not differentiate into
Th17 cells in the LP (Hand et al., 2012). More importantly, these
studies were performed in mice with undefined commensal
microbiota, which may contain multiple Th17 cell-inducing
species, including pathobionts such as Helicobacter spp (Mu¨ller
and Solnick, 2011). Therefore, the role of individual Th17-cell-
inducing commensals, such as SFB, has not been investigated,
and whether they preferentially induce commensal-specific
Th17 cells is not known.
Modification of Intestinal Epithelial Cell Function
IECs form a single-cell barrier that separates themicrobiota from
host tissues and immune cells. IECs also represent a cell type to
which both microbiota and immune cells have direct access and
may, therefore, play a major role in transmitting microbiota’s
immunomodulatory signals. There are multiple examples of
how commensal bacteria affect IEC function. Signals from mi-
crobiota are constantly being processed by IECs to maintain
proper barrier function (Hooper and Macpherson, 2010; Rak-
off-Nahoum et al., 2004). At the same time, IEC-produced cyto-
kines are crucial in modulating LP immune responses (He et al.,
2007; Saenz et al., 2008). Exactly how these two types of events
are connected is not completely clear. However, it is logical to
imagine a scenario whereby immunomodulatory commensals
modify IEC function either by directly binding to IECs or by
secreting substances that ligate IEC receptors on the apical
side. Following IEC activation, IEC-derived cytokines will be
secreted on the basolateral side to influence the activity of LP
immune cells, such as DCs, that in turn will affect T cell homeo-
stasis. Such sequence of events is highly likely, especially for
mucosa-associated autobionts. SFB are a prototypical example.
SFB colonize the intestine of many animal species in the post-
weaning period. The majority of microbiota are kept away from
direct contact with the epithelium by a layer of mucus enriched
in antimicrobial substances (Johansson et al., 2008; Vaishnava
et al., 2011). SFB differ from most commensals in that they can
penetrate the mucosal layer and adhere tightly to IECs in the
terminal ileum as well as to follicle-associated epithelium (FAE)
of Peyer’s patches (Klaasen et al., 1992). The host and bacterial
molecules involved in this adherence are unknown. However, the
interaction resembles ligation of a surface receptor on the IEC
apical site by a bacterial adhesin. Actin cytoskeletal reorganiza-
tion is seen in the IEC at the point of contact (Jepson et al., 1993),
which implies initiation of downstream signaling events and
modification of IEC function by the adhering commensal. Indeed,SFB are known to affect gene expression in IECs, includingMHC
class II expression, surface fucosylation, and antimicrobial
peptide production (Ivanov et al., 2009; Umesaki et al., 1995).
They also seem to induce cytokine-like molecules such as
SAA, which can modify the function of LP cells (Ivanov et al.,
2009). Whether adherence to IECs or any of these effects on
IEC function are required for the Th17 cell-inductive capacity
of SFB is not yet known. SFB interactionwith IECsmay also bring
the bacteria in close proximity to sampling cells, such as M cells
in PPs and intestinal villi or interdigitating DCs (Rescigno et al.,
2001). In any case, the strong association of SFB with IECs is
a unique feature of this commensal and is likely to be involved
in its immunomodulatory effects. Whether other mucosa-associ-
ated commensals also have strong immunomodulatory effects
remains to be investigated.
Modification of Host Metabolic Functions
Autobionts may influence the balance of intestinal immune cells
by generating immunomodulatory metabolites. Microbiota is
integral for the generation of dietary metabolites (Holmes et al.,
2012) and plays major role in metabolic conditions, such as
obesity (Turnbaugh et al., 2006), metabolic syndrome (Vijay-
Kumar et al., 2010), and nonalcoholic fatty liver disease (He-
nao-Mejia et al., 2012). In addition to energy harvest, microbial
metabolites have profound effects on immune responses. A
comparison of sera from GF and conventional mice by mass
spectrometry revealed that the microbiota play critical roles in
metabolizing tryptophan, phenylalanine, and tyrosine, and
producing tryptophan metabolites such as indoxyl sulfate and
the antioxidant indole-3-propionic acid (IPA), and other organic
acids containing phenyl groups, such as phenyl sulfate (Wikoff
et al., 2009). Importantly, these aromatic hydrocarbons are
known to influence the differentiation of T cells and ILCs (Qiu
et al., 2012; Veldhoen et al., 2008). The aryl hydrocarbon
receptor (AhR) is a receptor for tryptophan derivatives and has
been implicated in immune regulation by tryptophan metabo-
lites. AhR is expressed in differentiating Th17 cells, and AhR
ligands upregulate IL-22 expression and boost Th17 cell differ-
entiation (Veldhoen et al., 2008). Other reports have shown
that AhR activation can result in control of proinflammatory
responses and expansion of the Treg compartment (Gandhi
et al., 2010; Quintana et al., 2008). Thus, the control of Th17
and Treg differentiation by AhR seems to be complex. AhR is
also expressed by IL-22-producing ILCs and IELs, and AhR/
mice have fewer IL-22-producing ILCs and IELs in the intestine
(Li et al., 2011; Qiu et al., 2012). Tryptophan metabolism in
general may be important for T cell homeostasis. In this context,
it is noteworthy that IECs from mice colonized with 46 strains of
Clostridia express high levels of indoleamine 2,3-dioxygenase
(IDO) (Atarashi et al., 2011), an enzyme that degrades tryptophan
and has been implicated in Treg induction (Matteoli et al., 2010).
Furthermore, it has been shown that uptake of dietary amino
acids, including tryptophan, by IECs via the amino acid trans-
porter B0AT1 complexed with angiotensin-converting enzyme
2 (ACE2) is essential for the production of antimicrobial peptides
and control of gut microbial ecology (Hashimoto et al., 2012).
Therefore, it will be interesting to address the involvement of
amino acid metabolites in commensal-mediated immune modu-
lation.Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc. 503
Figure 1. Mutualistic Commensals with Immunomodulatory Effects Sustain Healthy Immune Homeostasis
Autobionts are permanent members of the normal commensal microbiota. They control immune homeostasis in the lamina propria by, for example, inducing
different subsets of effector T cells (control of T cell homeostasis). The relative proportions of Th17 and Treg cells depend on the relative presence of different
autobionts, e.g., in different individuals, different intestinal locations, or at different stages in ontogeny. These mutualistic interactions sustain the healthy steady
state. Loss of autobionts and general dysbiosis perturbs also the immune balance of the host. Dysbiosismay occur inmultiple ways. Invasive intestinal pathogens
cause transient infections but may lead to long-term perturbations of the microbiota due to strong inflammatory responses against the pathogen. Antibiotic (Abx)
treatments or inflammation caused by physical damage to the mucosa may also lead to dysbiosis and the outgrowth of pathobionts, which are permanent
members of themicrobiota but do not cause disease in the presence of autobionts. Host genetic factorsmay also initiate or perpetuate dysbiosis. Dysbiosis leads
to loss of the immunomodulatory effects of autobionts and results in a perturbed immune balance, which under appropriate conditions may manifest itself in
disease. The disease state augments dysbiosis in a vicious circle. Autobionts and conventional probiotics are both mircoorganisms with beneficial effects.
Probiotics have transient effects and can boost host immunity. Autobionts are part of the normal microbiota and have developed evolutionary adaptations to
colonize the host, regulate host immunity, and establish a healthy immune state. Autobionts can therefore reverse dysbiosis as well as immune homeostasis.
Cell Host & Microbe
ReviewBacteroidetes and Clostridia employ a wide variety of
enzymes capable of degrading polysaccharides and oligosac-
charides into short chain fatty acids (SCFAs), such as acetic
acid, propionic acid, and butyric acid (Flint et al., 2008). SCFAs
influence host physiology, including gut motility and colonocyte
development. In addition, SCFAs contribute to maintenance of
intestinal immune homeostasis. Indeed, butyrate metabolism is
impaired in patients with ulcerative colitis, and topical sodium
butyrate treatments or butyrate enemas are effective therapies504 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.(Scheppach et al., 1992; Vernia et al., 2003). GF mice are highly
susceptible to dextran sulfate sodium (DSS)-mediated colitis,
but treatment of GFmice with acetate in drinking water markedly
improves colitis disease indices (Maslowski et al., 2009). SCFAs
are known to act as extracellular signaling molecules that
activate G protein-coupled receptors, such as GPR41 and
GPR43. GPR41 is expressed by a subset of IECs and controls
microbiota effects on energy harvest and obesity (Samuel
et al., 2008). GPR43 is expressed by neutrophils and eosinophils
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Gpr43/ neutrophils have an intrinsic hyperreactive phenotype,
including hyperproduction of reactive oxygen species (ROS),
and high chemotactic activity (Maslowski et al., 2009). It is not
known whether SCFA signaling is involved in the induction of
Th17 cells and Tregs by autobionts. However, considering that
Bacteroidetes and Firmicutes are high producers of SCFAs (Flint
et al., 2008), SCFA-GPR signaling may represent an important
molecular pathway activated by commensals to regulate
immune and inflammatory responses and maintain the mucosal
barrier.
Therapeutical Use of Intestinal Microbes or Their
Products
Alteration of the gut microbiota in humans via fecal transplants of
stool from healthy donors has been effective in a large number of
case studies of refractory C. difficile infection (Khoruts and
Sadowsky, 2011). While fecal transplantation has established
a proof of principle for the feasibility of manipulating human
microbiota as a therapeutic strategy (Khoruts and Sadowsky,
2011), treatment with specific microorganisms is more desirable
for medical purposes. Many of the conventional probiotic micro-
organisms were traditionally used to preserve food products by
fermentation and are not necessarily part of the normal micro-
biota (O’Toole and Cooney, 2008). In other words, no probiotic
has been rationally isolated from themicrobiota with the purpose
of boosting specific arms of the host immune system or to fix
a particular commensal dysbiosis. As described earlier, several
lines of evidence suggest that dysbiotic microbiota can be
a highly stable complex and therefore refractory to treatment
with individual transient probiotic strains. Indeed, despite prom-
ising data from animal models, most probiotics tested to date
have demonstrated, at best, mediocre effects in the clinic,
particularly for treatment of IBD. Thus, there is a compelling
need to identify more robust therapeutic organisms that are
compatible to the host and can affect the host immune system
in a well-controlled, physiological fashion. Ideally, these organ-
isms will be able to induce broader changes to the microbial
ecosystemand have the ability to ameliorate dysbiosis (Figure 1).
Such therapeutic organisms may include some traditional probi-
otics, but immunomodulatory autobionts represent the most
promising candidates. Autobionts are capable of becoming
permanent members of the microbiota and therefore may be
able to restore dysbiosis and inhibit the growth of pathogens
or pathobionts. Indeed, SFB colonization can reduce replication
of enteropathogenic E. coli in rabbits (Heczko et al., 2000),
Salmonella enteritidis in rats (Garland et al., 1982), and Citro-
bacter rodentium in mice (Ivanov et al., 2009). Colonization
with indigenous Clostridia and Lactobacilli isolated from conven-
tional mice was shown to effectively control E. coli expansion in
the large intestine of mice (Itoh and Freter, 1989). At the same
time, autobionts have focused on independent effects on the
immune system that are relatively more subtle and aimed at
sustaining intestinal immune homeostasis. SFB and Clostridia
induce controlled expansion of Th17 cells or Tregs indepen-
dently of each other, and the induced Th17 or Treg cells do
not exceed the levels in SPFmice and do not cause overt inflam-
matory disease or immune deficiency. Therefore, the mecha-
nisms controlling autobiont-induced immune effects are more‘‘physiological.’’ Characterization of the cellular and molecular
mechanisms responsible for the effects in each example of
autobiont-host interaction is crucial in designing therapies that
will not rely on colonization with live bacteria, but instead use
specific small molecules which mimic their beneficial effects.
For example, even though SFB have not yet been found in
human metagenomic databases (Sczesnak et al., 2011), the
molecular and cellular mechanisms of SFB immune modulation
may still be preserved and taken on by other commensals in
humans. Characterization of such molecular mechanisms will
allow for development of rationally designed combinations of
targeting agents to boost the immune system in a desired way
or correct effects of intestinal dysbiosis to treat various immune
diseases.
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